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Abstract
Background: Hyperhomocysteinemia is an independent risk factor for stroke and other vascular events. The variant
methylenetetrahydrofolate reductase (MTHFR) C677T is associated with elevated homocysteine levels, cardiovascular
disease and stroke, which supports a causal relationship between hyperhomocysteinemia and vascular disease. However,
MTHFR variants have also been reported to be associated with smoking behavior, which could be an important confounder.
Methodology/Principal Findings: We analyzed the MTHFR variants C677T and A1298C in two independent samples of 525
and 535 individuals, respectively. 21% of the non-smokers, but only 12% of the smokers were homozygous carriers of both
MTHFR wildtype alleles, i.e. 677CC and 1298AA (Chi2 = 15.8; p,0.001; binary regression). Plasma homocysteine levels were
higher in smokers (13.964.1 mmol/L) than in non-smokers (12.664.0 mmol/L; F = 11.4; p = 0.001; ANOVA). Smoking MTHFR
677TT individuals had the highest plasma homocysteine levels (16.265.2 mmol/L), non-smoking 677CC individuals had the
lowest (12.2613.6 mmol/L).
Conclusions/Significance: In our study samples, MTHFR variants and smoking behaviour were associated with
homocysteine plasma levels. In addition, the MTHFR variants were associated with smoking behaviour. Such an association
may be a relevant confounder between MTHFR variants, homocysteine plasma levels and vascular diseases.
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Introduction
Hyperhomocysteinemia is an independent risk factor for stroke
and other vascular events (OMIM 603174). The association of the
T-allele of MTHFR C677T (A222V) with hyperhomocysteinemia,
cardiovascular disease and stroke suggests a causal relationship
between hyperhomocysteinemia and vascular disease, and a meta-
analysis stated evidence for causality from Mendelian randomisa-
tion, arguing that the observed increase in the risk of stroke among
individuals homozygous for the T-allele is close to that predicted
from the differences in homocysteine concentration conferred by
this variant [1]. However, the editorial comment on that article
pointed out, that the groups defined by the MTHFR C677T
genotypes ‘‘should not differ systematically in any other way. For example,
those with the TT genotype should not be more likely to be smokers … than
individuals with the CC genotype’’[1]. Such an association would be a
possible important confounder between MTHFR, homocysteine
plasma levels, smoking and vascular events like stroke. A few
studies investigated such linkage of the MTHFR genotype with
smoking behaviour. In 2001, a study including 232 Hispanic
pregnant women revealed a significantly higher rate of smoking
(0.59) in TT homozygotes compared with heterozygotes (0.21) or
CC homozygotes (0.34). Re-calculation of this data reveals a
higher rate of the TT genotype in smokers (0.15) than in non-
smokers (0.04) [2]. Newer and larger studies did not provide
conclusive data whether smoking is associated with the MTHFR
C677T variant. For example, Brown et al. (n = 407) observed a
TT genotype frequency of 0.16 in smokers and of 0.12 in non-
smokers (not significant) [3]. Liu et al. (n = 1074) reported a higher
frequency of the TT genotype in smokers (0.17) than in non-
smokers (0.11), but this difference was not statistically tested [4],
Husemoen et al did not observe an association of the C677T
genotype with daily smoking in 2788 Danish men and women
aged 30–60 years [5]. In a small population, Imyanitov et al.
reported a higher frequency of homozygosity for the wild-type
allele of another MTHFR missense variant, i.e. A1298C, in non-
smokers versus smokers, but this was not tested for significance.
The C677T genotype was without difference [6]. The two
mentioned MTHFR variants, C677T and A1298C, are in linkage
disequilibrium, i.e. the haplotype with the two mutant variants
677T;1298C is rare [7]. In addition to possible genetic associa-
tions, smoking is associated with increased homocysteine plasma
levels, and smoking and MTHFR C677T may interact concerning
the association with homocysteine plasma levels [3]. In this study,
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we aimed at analysing the association of MTHFR genotypes with
smoking in two independent samples of 525 and 535 individuals.
Methods
Objectives
The available data on the association of MTHFR C677T and
A1298C with smoking behaviour is inconclusive. We aimed at
analysing MTHFR genotypes and smoking behaviour and their
possible interaction regarding homocysteine plasma levels in
further populations. As the MTHFR enzyme is a homodimer,
missense variants on different alleles in the sense of combined
heterozygosity may lead to relevant interactions on the protein
level, as in a mixed dimer, amino acid exchanges on one of the
strains may influence the other [8]. Thus, we decided to analyse
MTHFR C677T; A1298C haplotypes and genotypes instead of
analysing these two variants separately to test the hypothesis that
the MTHFR genotype defined by C677T and A1298C is
associated with smoking behaviour.
Participants
We analyzed two independent samples, 1060 individuals in total
(table 1). Sample 1 (n = 525) consisted of serial in- and outpatients
of the division of ultrasonography of the Department of Neurology
of the University Hospital Bonn in addition to patients’ partners
recruited within an ongoing study [2]. Mean age was 48.8616.0
years, 271 individuals were female, 254 male. Smoking status was
defined by self-reported current smoking status, categorized as
either smokers or non-smokers.
Sample 2 was recruited from an ongoing smoking cessation
study run by the Department of Psychiatry, University Hospital
Bonn: 388 serial current smokers living in the area of Bonn and
147 population controls, i.e. never-smokers. Mean age was
40.0612.5 years, 245 individuals were female, 290 male. Status
‘‘current smoking’’ was defined by smoking a minimum of 15
cigarettes per day for more than two years. In both samples, only
unrelated individuals of Caucasian ancestry were enrolled.
Description of Procedures or Investigations undertaken
Total homocysteine plasma levels were analyzed in the clinical
routine in the University Hospital Bonn for sample 1, but were not
available for sample 2. MTHFR C677T and A1298AC were
analyzed by polymerase chain reaction amplification with
subsequent allele-specific endonuclease restriction and agarose
gel electrophoresis as published [3]. For quality control, each 5th
sample was analysed twice. We aimed to analyse the association of
the variant MTHFR genotypes with smoking behaviour. As
strategy for analysis, we made use of the linkage disequilibrium of
MTHFR C677T and A1298C: Because of the linkage disequilib-
rium, only three MTHFR C677T;A1298C haplotypes occur with
relevant frequency: 677C;1298A, 677C;1298C and 677T;1298A.
Thus, we grouped the resulting genotypes:
1) wild-type for both alleles (677CC;1298AA),
2) homozygous for one mutant variant (677TT;1298AA or
677CC;1298CC),
3) heterozygous for one or both mutant variants
(.677CT;1298AA or 677CT;1298AC or 677CC;1298AC)
[3].
Statistical methods
Genotype distributions were tested by Chi2 goodness-of-fit test.
Due to differences of age and gender between smokers and non-
smokers, logistic regression models adjusted for age and sex with
smoking status as dependent variable were used for statistical
analyses. For the analyses of homocysteine plasma levels as
dependent variable and MTHFR genotypes, smoking status, age
and gender as covariables, multivariate linear regression analysis
was used. Due to the different recruitment strategies and criteria,
samples 1 and 2 were analyzed separately in addition to a pooled
analysis. Homocysteine plasma levels were exploratively compared
between groups defined by MTHFR variants of smoking
behaviour using ANOVA.
Ethics
This study has been conducted according to the principles
expressed in the Declaration of Helsinki. The study was approved
by the local ethics committee (Ethikkommission an der Medizi-
nischen Fakulta¨t der Universita¨t Bonn). All patients gave written
informed consent.
Results
Genotyping succeeded for all DNA samples. The genotype
distribution did not deviate from the Hardy-Weinberg equation.
The wild-type genotype 677CC; 1298AA was more common in
non-smokers than in smokers in sample 1 (Chi2 = 7.6; p = 0.022),
in sample 2 (Chi2 = 6.0; p = 0.051 for trend) and in the pooled
sample (Chi2 = 15.8; p,0.001; table 2).
The T-allele of MTHFR 677C.T was associated with higher
homocysteine levels showing a gene-dose effect (B= 1.0; p,0.001;
Table 3). In addition, homocysteine levels were higher in smokers
(13.964.1 mmol/L) than in non-smokers (12.664.0 mmol/L;
F= 11.4; p = 0.001; ANOVA). Stratification by smoking behav-
iour and MTHFR C677T revealed an interaction between these
two factors on homocysteine plasma levels: smokers and homo-
cysteine plasma levels (C677T genotype): 13.464.2 mmol/L (CC),
13.963.8 mmol/L (CT), and 16.265.2 mmol/L (TT), and non-
smokers: 12.2613.6 mmol/L (CC), 12.764.0 mmol/L (CT), and
14.464.0 mmol/L (TT). Thus, smoking MTHFR 677TT individ-
uals had the highest plasma homocysteine levels, non-smoking
677CC individuals the lowest.
Discussion
The mutant alleles of the variants MTHFR C677T and, with
less evidence, A1298C are associated with both elevated homo-
cysteine plasma levels and vascular diseases arguing for hyperho-
mocysteinemia as a causal risk factor for vascular disease [1].
However, there are inconclusive data that these MTHFR variants
may questionably also be associated with smoking behaviour
Table 1. Demographic data.
sample 1 sample 2 all
525 535 1060
smokers n 311 388 699
smokers: ratio female 0.42 0.48 0.45
smokers: mean age 48.4y615.2 41.6612.8 47.0615.0
non-smokers n 214 147 361
non-smokers: ratio female 0.66 0.40 0.55
non-smokers: mean age 49.4617.2 35.8611.6 43.9616.6
doi:10.1371/journal.pone.0053322.t001
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[2,3,4,5,6]. Such an association would be an important confound-
er concerning the role of elevated homocysteine plasma levels as a
vascular risk factor. In two selected cohorts, we analysed MTHFR
C677T;A1298C haplotypes and observed that likelihood of being
a smoker was lowest in those subjects homozygous for the wild-
type-alleles677CC and 1298AA, while presence of a mutant allele
increased the likelihood of being a smoker. MTHFR is expressed
in the brain and is involved in remethylation of homocysteine to
methionine, which can be activated to S-adenosylmethionine
functioning as methyl group donor, e.g. for the synthesis of
neurotransmitters and dopamine methylation [9]. Whether an
influence of MTHFR variants on such biochemical pathways may
Table 2. MTHFR variants in smokers and non-smokers.
all individuals (samples 1+2; n=1060)
c.677C.T CC CT TT nominal regression
smokers (n = 699) 0.41 0.47 0.12 Chi2 = 5.5; p = 0.064
non-smokers (n = 361) 0.49 0.42 0.09
c.1298A.C AA AC CC
smokers (n = 699) 0.46 0.43 0.11 Chi2 = 6.4; p = 0.040
non-smokers (n = 361) 0.53 0.38 0.10
c.677C.T;c.1298A.C c.677CC;c.1298AA c.677TT;c.1298AA or c.677CC;c.1298CC all others
smokers (n = 699) 0.12 0.22 0.66 Chi2 = 15.8; p,0.001
non-smokers (n = 361) 0.21 0.19 0.60
sample 1; n =525
c.677C.T CC CT TT nominal regression
smokers (n = 311) 0.44 0.46 0.09 Chi2 = 3.7; p = 0.159
non-smokers (n = 214) 0.50 0.42 0.07
c.1298A.C AA AC CC
smokers (n = 311) 0.45 0.45 0.10 Chi2 = 4.3; p = 0.116
non-smokers (n = 214) 0.53 0.40 0.07
c.677C.T;c.1298A.C c.677CC;c.1298AA c.677TT;c.1298CC or c.677CC;c.1298CC all others
smokers (n = 311) 0.14 0.19 0.67 Chi2 = 7.6; p = 0.022
non-smokers (n = 214) 0.23 0.15 0.62
sample 2; n =535
c.677C.T CC CT TT nominal regression
smokers (n = 388) 0.39 0.47 0.14 Chi2 = 4.7; p = 0.095
non-smokers (n = 147) 0.48 0.41 0.12
c.1298A.C AA AC CC
smokers (n = 388) 0.47 0.41 0.11 Chi2 = 2.9; p = 0.234
non-smokers (n = 147) 0.52 0.35 0.13
c.677C.T;c.1298A.C c.677CC;c.1298AA c.677TT;c.1298CC or c.677CC;c.1298CC all others
smokers (n = 388) 0.10 0.24 0.66 Chi2 = 6.0; p = 0.051
non-smokers (n = 147) 0.18 0.24 0.58
Genotype frequencies concerning the two alleles MTHFR c.6777C.T and MTHFR c.1298A.C as well as the genotype frequencies resulting from the
c.677C.T;c.1298A.C haplotypes.
doi:10.1371/journal.pone.0053322.t002
Table 3. Homocysteine levels and MTHFR variants.
c.677C.T CC CT TT linear regression
homocysteine 12.964.0 13.563.9 15.565.4 B = 1.0; p,0.001
c.1298A.C AA AC CC linear regression
homocysteine 13.564.3 13.264.1 13.363.7 B = 0.01; p = 0.944
c.677C.T;c.1298A.C MTHFR c.677CC & MTHFR c.1298AA all others MTHFR c.677TT or MTHFR c.1298CC linear regression
homocysteine 12.463.7 13.464.0 14.464.7 B = 0.8; p = 0.008
Fasting total plasma homocysteine levels in mmol/l 6 one standard deviation.
doi:10.1371/journal.pone.0053322.t003
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explain an association of these variants with smoking behaviour,
remains speculative. Smoking is known to be associated with
higher homocysteine plasma levels [5,6]. Moreover, our data
confirm that the T allele of MTHFR C677T and smoking interact
in their association with homocysteine plasma levels, i.e. smoking
homozygous T carriers had highest, non-smoking homozygous C
carriers lowest homocysteine plasma levels [3].
Our study has several important limitations: Two heteroge-
neous study samples were retrospectively analysed. Both do not
represent the normal population, but were recruited for studies on
smoking cessation and atherosclerosis, respectively, which may
have led to relevant selection bias as shown by the high rate of
smokers. Controls did not completely match, thus, multivariate
analyses were necessary. Further, such analysis of genotypes and
smoking were initially not planned for sample 1, thus, information
on smoking status was limited, i.e. ‘‘yes’’ versus ‘‘no’’ without clear
definition. Further, we adjusted for age and sex, but other possible
confounders like birth cohort effects and alcohol use were not
regarded due to limited information. Results were only significant,
if the two population samples were pooled, but only for trend or
not in separate analyses, which would have been preferable due to
the differences between those two samples. However, our data
support to the theory that MTHFR C677T and smoking interact
in generating elevated homocysteine plasma levels via unknown
mechanisms. Such information may be relevant for the stratifica-
tion of vascular risk factors. Moreover, our data suggest that
MTHFR alleles with at least one of the mutant variants C677T
and A1298C are associated with smoking. Published previous
studies were inconclusive concerning such an association, which
would be a relevant confounder concerning the association of
MTHFR variants, hyperhomocysteinemia and vascular events.
Speculatively, the difference between our findings – compared to
prior negative results on associations between MTHFR genotype
and smoking – may be due to analysing both variant regions
C677T and A1298C simultaneously. Indeed, when C677T is
analysed alone in our subjects, the difference between smokers and
non-smokers was not significant. It may be justified that statistical
strategies of future studies on the role of homocysteine metabolism
in vascular disease regard such possible associations.
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